schliessen

Filtern

 

Bibliotheken

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

Objective: Women with polycystic ovary syndrome (PCOS) often have cardiovascular disease (CVD) risk factors. The Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society created a panel to provide evidence-based reviews of studies assessing PCOS-CVD risk relationships and to develop guideline... Full description

Journal Title: The journal of clinical endocrinology and metabolism 2010, Vol.95 (5), p.2038-2049
Main Author: Wild, Robert A
Other Authors: Carmina, Enrico , Diamanti-Kandarakis, Evanthia , Dokras, Anuja , Escobar-Morreale, Hector F , Futterweit, Walter , Lobo, Rogerio , Norman, Robert J , Talbott, Evelyn , Dumesic, Daniel A
Format: Electronic Article Electronic Article
Language: English
Subjects:
Publisher: Bethesda, MD: Endocrine Society
ID: ISSN: 0021-972X
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_proquest_miscellaneous_733104706
title: Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
format: Article
creator:
  • Wild, Robert A
  • Carmina, Enrico
  • Diamanti-Kandarakis, Evanthia
  • Dokras, Anuja
  • Escobar-Morreale, Hector F
  • Futterweit, Walter
  • Lobo, Rogerio
  • Norman, Robert J
  • Talbott, Evelyn
  • Dumesic, Daniel A
subjects:
  • Abridged Index Medicus
  • Atherosclerosis - diagnosis
  • Atherosclerosis - epidemiology
  • Biological and medical sciences
  • Body Mass Index
  • Cardiovascular Diseases - epidemiology
  • Cardiovascular Diseases - mortality
  • Cardiovascular Diseases - prevention & control
  • Diabetes Mellitus, Type 2 - epidemiology
  • Diabetes Mellitus, Type 2 - mortality
  • Endocrinopathies
  • Feeding. Feeding behavior
  • Female
  • Fundamental and applied biological sciences. Psychology
  • Glucose Intolerance - epidemiology
  • Glucose Intolerance - mortality
  • Humans
  • Medical sciences
  • Polycystic Ovary Syndrome - complications
  • Risk Assessment
  • Risk Factors
  • Vertebrates: anatomy and physiology, studies on body, several organs or systems
  • Vertebrates: endocrinology
  • Waist-Hip Ratio
ispartof: The journal of clinical endocrinology and metabolism, 2010, Vol.95 (5), p.2038-2049
description: Objective: Women with polycystic ovary syndrome (PCOS) often have cardiovascular disease (CVD) risk factors. The Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society created a panel to provide evidence-based reviews of studies assessing PCOS-CVD risk relationships and to develop guidelines for preventing CVD. Participants: An expert panel in PCOS and CVD reviewed literature and presented recommendations. Evidence: Only studies comparing PCOS with control patients were included. All electronic databases were searched; reviews included individual studies/databases, systematic reviews, abstracts, and expert data. Articles were excluded if other hyperandrogenic disorders were not excluded, PCOS diagnosis was unclear, controls were not described, or methodology precluded evaluation. Inclusion/exclusion criteria were confirmed by at least two reviewers and arbitrated by a third. Consensus Process: Systematic reviews of CVD risk factors were compiled and submitted for approval to the AE-PCOS Society Board. Conclusions: Women with PCOS with obesity, cigarette smoking, dyslipidemia, hypertension, impaired glucose tolerance, and subclinical vascular disease are at risk, whereas those with metabolic syndrome and/or type 2 diabetes mellitus are at high risk for CVD. Body mass index, waist circumference, serum lipid/glucose, and blood pressure determinations are recommended for all women with PCOS, as is oral glucose tolerance testing in those with obesity, advanced age, personal history of gestational diabetes, or family history of type 2 diabetes mellitus. Mood disorder assessment is suggested in all PCOS patients. Lifestyle management is recommended for primary CVD prevention, targeting low-density and non-high-density lipoprotein cholesterol and adding insulin-sensitizing and other drugs if dyslipidemia or other risk factors persist. Guidelines for assessing cardiovascular risk and for primary prevention of cardiovascular diseases in PCOS.
language: eng
source:
identifier: ISSN: 0021-972X
fulltext: no_fulltext
issn:
  • 0021-972X
  • 1945-7197
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.7653546
LOCALfalse
PrimoNMBib
record
control
sourceidproquest_cross
recordidTN_cdi_proquest_miscellaneous_733104706
sourceformatXML
sourcesystemPC
sourcerecordid733104706
originalsourceidFETCH-LOGICAL-14577-2d1acd4f4119df393ff1ab21f141afab495da616e6dff5fade7462b66d0923780
addsrcrecordideNp1kV1v0zAUhiMEYmVwxzXyDQIkMmzHiZfdVaV8SJM6URDcWa59TN2ldrGdlvxPfhDuWkBCm28iWc_7nuM8RfGU4DNCCX6zUmcU47aknLJ7xYi0rC45afn9YoQxJWXL6beT4lGMK4wJY3X1sDihuOI1xfWo-DWOEWJcg0vIGzSRQVu_lVH1nQzok43XSDqNrgJsM2K9u4V6ayPICMg69NXnJrSzaYnSEtCV7wY1xGQVmm1lGNB8cDpk5gKN0cS7CC72Ec2TTHCzwmK4yY331PfcNP2p8naHFe7qQi_H0_JqMpu_QnOvLKThcfHAyC7Ck-P3tPjybvp58qG8nL3_OBlfloTVnJdUE6k0M4yQVpuqrYwhckGJIYxIIxesrbVsSAONNqY2UgNnDV00jcYtrfg5Pi1eHHo3wf_oISaxtlFB10kHvo-CVxXBjOMmk68PpAo-xgBGbIJd51cIgsVeo1gpsdco9hoz_uxY3C_WoP_Cf7xl4PkRyBJkZ4J0ysZ_HOVNVfE2c_S_ucrmn509piBtd9d0dgjtfJcgxOuu30EQS5BdWgqcD2v4eUkxwXkVjMv9Fc-x6hADp70K1sEmZHli5fvgsobbh_0Gd-jaTw
sourcetypeAggregation Database
isCDItrue
recordtypearticle
pqid733104706
display
typearticle
titleAssessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
creatorWild, Robert A ; Carmina, Enrico ; Diamanti-Kandarakis, Evanthia ; Dokras, Anuja ; Escobar-Morreale, Hector F ; Futterweit, Walter ; Lobo, Rogerio ; Norman, Robert J ; Talbott, Evelyn ; Dumesic, Daniel A
creatorcontribWild, Robert A ; Carmina, Enrico ; Diamanti-Kandarakis, Evanthia ; Dokras, Anuja ; Escobar-Morreale, Hector F ; Futterweit, Walter ; Lobo, Rogerio ; Norman, Robert J ; Talbott, Evelyn ; Dumesic, Daniel A
descriptionObjective: Women with polycystic ovary syndrome (PCOS) often have cardiovascular disease (CVD) risk factors. The Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society created a panel to provide evidence-based reviews of studies assessing PCOS-CVD risk relationships and to develop guidelines for preventing CVD. Participants: An expert panel in PCOS and CVD reviewed literature and presented recommendations. Evidence: Only studies comparing PCOS with control patients were included. All electronic databases were searched; reviews included individual studies/databases, systematic reviews, abstracts, and expert data. Articles were excluded if other hyperandrogenic disorders were not excluded, PCOS diagnosis was unclear, controls were not described, or methodology precluded evaluation. Inclusion/exclusion criteria were confirmed by at least two reviewers and arbitrated by a third. Consensus Process: Systematic reviews of CVD risk factors were compiled and submitted for approval to the AE-PCOS Society Board. Conclusions: Women with PCOS with obesity, cigarette smoking, dyslipidemia, hypertension, impaired glucose tolerance, and subclinical vascular disease are at risk, whereas those with metabolic syndrome and/or type 2 diabetes mellitus are at high risk for CVD. Body mass index, waist circumference, serum lipid/glucose, and blood pressure determinations are recommended for all women with PCOS, as is oral glucose tolerance testing in those with obesity, advanced age, personal history of gestational diabetes, or family history of type 2 diabetes mellitus. Mood disorder assessment is suggested in all PCOS patients. Lifestyle management is recommended for primary CVD prevention, targeting low-density and non-high-density lipoprotein cholesterol and adding insulin-sensitizing and other drugs if dyslipidemia or other risk factors persist. Guidelines for assessing cardiovascular risk and for primary prevention of cardiovascular diseases in PCOS.
identifier
0ISSN: 0021-972X
1EISSN: 1945-7197
2DOI: 10.1210/jc.2009-2724
3PMID: 20375205
4CODEN: JCEMAZ
languageeng
publisherBethesda, MD: Endocrine Society
subjectAbridged Index Medicus ; Atherosclerosis - diagnosis ; Atherosclerosis - epidemiology ; Biological and medical sciences ; Body Mass Index ; Cardiovascular Diseases - epidemiology ; Cardiovascular Diseases - mortality ; Cardiovascular Diseases - prevention & control ; Diabetes Mellitus, Type 2 - epidemiology ; Diabetes Mellitus, Type 2 - mortality ; Endocrinopathies ; Feeding. Feeding behavior ; Female ; Fundamental and applied biological sciences. Psychology ; Glucose Intolerance - epidemiology ; Glucose Intolerance - mortality ; Humans ; Medical sciences ; Polycystic Ovary Syndrome - complications ; Risk Assessment ; Risk Factors ; Vertebrates: anatomy and physiology, studies on body, several organs or systems ; Vertebrates: endocrinology ; Waist-Hip Ratio
ispartofThe journal of clinical endocrinology and metabolism, 2010, Vol.95 (5), p.2038-2049
rights
0Copyright © 2010 by The Endocrine Society
12015 INIST-CNRS
lds50peer_reviewed
oafree_for_read
citedbyFETCH-LOGICAL-14577-2d1acd4f4119df393ff1ab21f141afab495da616e6dff5fade7462b66d0923780
citesFETCH-LOGICAL-14577-2d1acd4f4119df393ff1ab21f141afab495da616e6dff5fade7462b66d0923780
links
openurl$$Topenurl_article
thumbnail$$Usyndetics_thumb_exl
backlink
0$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22763379$$DView record in Pascal Francis
1$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20375205$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0Wild, Robert A
1Carmina, Enrico
2Diamanti-Kandarakis, Evanthia
3Dokras, Anuja
4Escobar-Morreale, Hector F
5Futterweit, Walter
6Lobo, Rogerio
7Norman, Robert J
8Talbott, Evelyn
9Dumesic, Daniel A
title
0Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
1The journal of clinical endocrinology and metabolism
addtitleJ Clin Endocrinol Metab
descriptionObjective: Women with polycystic ovary syndrome (PCOS) often have cardiovascular disease (CVD) risk factors. The Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society created a panel to provide evidence-based reviews of studies assessing PCOS-CVD risk relationships and to develop guidelines for preventing CVD. Participants: An expert panel in PCOS and CVD reviewed literature and presented recommendations. Evidence: Only studies comparing PCOS with control patients were included. All electronic databases were searched; reviews included individual studies/databases, systematic reviews, abstracts, and expert data. Articles were excluded if other hyperandrogenic disorders were not excluded, PCOS diagnosis was unclear, controls were not described, or methodology precluded evaluation. Inclusion/exclusion criteria were confirmed by at least two reviewers and arbitrated by a third. Consensus Process: Systematic reviews of CVD risk factors were compiled and submitted for approval to the AE-PCOS Society Board. Conclusions: Women with PCOS with obesity, cigarette smoking, dyslipidemia, hypertension, impaired glucose tolerance, and subclinical vascular disease are at risk, whereas those with metabolic syndrome and/or type 2 diabetes mellitus are at high risk for CVD. Body mass index, waist circumference, serum lipid/glucose, and blood pressure determinations are recommended for all women with PCOS, as is oral glucose tolerance testing in those with obesity, advanced age, personal history of gestational diabetes, or family history of type 2 diabetes mellitus. Mood disorder assessment is suggested in all PCOS patients. Lifestyle management is recommended for primary CVD prevention, targeting low-density and non-high-density lipoprotein cholesterol and adding insulin-sensitizing and other drugs if dyslipidemia or other risk factors persist. Guidelines for assessing cardiovascular risk and for primary prevention of cardiovascular diseases in PCOS.
subject
0Abridged Index Medicus
1Atherosclerosis - diagnosis
2Atherosclerosis - epidemiology
3Biological and medical sciences
4Body Mass Index
5Cardiovascular Diseases - epidemiology
6Cardiovascular Diseases - mortality
7Cardiovascular Diseases - prevention & control
8Diabetes Mellitus, Type 2 - epidemiology
9Diabetes Mellitus, Type 2 - mortality
10Endocrinopathies
11Feeding. Feeding behavior
12Female
13Fundamental and applied biological sciences. Psychology
14Glucose Intolerance - epidemiology
15Glucose Intolerance - mortality
16Humans
17Medical sciences
18Polycystic Ovary Syndrome - complications
19Risk Assessment
20Risk Factors
21Vertebrates: anatomy and physiology, studies on body, several organs or systems
22Vertebrates: endocrinology
23Waist-Hip Ratio
issn
00021-972X
11945-7197
fulltextfalse
rsrctypearticle
creationdate2010
recordtypearticle
recordideNp1kV1v0zAUhiMEYmVwxzXyDQIkMmzHiZfdVaV8SJM6URDcWa59TN2ldrGdlvxPfhDuWkBCm28iWc_7nuM8RfGU4DNCCX6zUmcU47aknLJ7xYi0rC45afn9YoQxJWXL6beT4lGMK4wJY3X1sDihuOI1xfWo-DWOEWJcg0vIGzSRQVu_lVH1nQzok43XSDqNrgJsM2K9u4V6ayPICMg69NXnJrSzaYnSEtCV7wY1xGQVmm1lGNB8cDpk5gKN0cS7CC72Ec2TTHCzwmK4yY331PfcNP2p8naHFe7qQi_H0_JqMpu_QnOvLKThcfHAyC7Ck-P3tPjybvp58qG8nL3_OBlfloTVnJdUE6k0M4yQVpuqrYwhckGJIYxIIxesrbVsSAONNqY2UgNnDV00jcYtrfg5Pi1eHHo3wf_oISaxtlFB10kHvo-CVxXBjOMmk68PpAo-xgBGbIJd51cIgsVeo1gpsdco9hoz_uxY3C_WoP_Cf7xl4PkRyBJkZ4J0ysZ_HOVNVfE2c_S_ucrmn509piBtd9d0dgjtfJcgxOuu30EQS5BdWgqcD2v4eUkxwXkVjMv9Fc-x6hADp70K1sEmZHli5fvgsobbh_0Gd-jaTw
startdate201005
enddate201005
creator
0Wild, Robert A
1Carmina, Enrico
2Diamanti-Kandarakis, Evanthia
3Dokras, Anuja
4Escobar-Morreale, Hector F
5Futterweit, Walter
6Lobo, Rogerio
7Norman, Robert J
8Talbott, Evelyn
9Dumesic, Daniel A
general
0Endocrine Society
1Copyright by The Endocrine Society
scope
0IQODW
1CGR
2CUY
3CVF
4ECM
5EIF
6NPM
7AAYXX
8CITATION
97X8
sort
creationdate201005
titleAssessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
authorWild, Robert A ; Carmina, Enrico ; Diamanti-Kandarakis, Evanthia ; Dokras, Anuja ; Escobar-Morreale, Hector F ; Futterweit, Walter ; Lobo, Rogerio ; Norman, Robert J ; Talbott, Evelyn ; Dumesic, Daniel A
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-14577-2d1acd4f4119df393ff1ab21f141afab495da616e6dff5fade7462b66d0923780
rsrctypearticles
prefilterarticles
languageeng
creationdate2010
topic
0Abridged Index Medicus
1Atherosclerosis - diagnosis
2Atherosclerosis - epidemiology
3Biological and medical sciences
4Body Mass Index
5Cardiovascular Diseases - epidemiology
6Cardiovascular Diseases - mortality
7Cardiovascular Diseases - prevention & control
8Diabetes Mellitus, Type 2 - epidemiology
9Diabetes Mellitus, Type 2 - mortality
10Endocrinopathies
11Feeding. Feeding behavior
12Female
13Fundamental and applied biological sciences. Psychology
14Glucose Intolerance - epidemiology
15Glucose Intolerance - mortality
16Humans
17Medical sciences
18Polycystic Ovary Syndrome - complications
19Risk Assessment
20Risk Factors
21Vertebrates: anatomy and physiology, studies on body, several organs or systems
22Vertebrates: endocrinology
23Waist-Hip Ratio
toplevelpeer_reviewed
creatorcontrib
0Wild, Robert A
1Carmina, Enrico
2Diamanti-Kandarakis, Evanthia
3Dokras, Anuja
4Escobar-Morreale, Hector F
5Futterweit, Walter
6Lobo, Rogerio
7Norman, Robert J
8Talbott, Evelyn
9Dumesic, Daniel A
collection
0Pascal-Francis
1Medline
2MEDLINE
3MEDLINE (Ovid)
4MEDLINE
5MEDLINE
6PubMed
7CrossRef
8MEDLINE - Academic
jtitleThe journal of clinical endocrinology and metabolism
delivery
delcategoryRemote Search Resource
fulltextno_fulltext
addata
au
0Wild, Robert A
1Carmina, Enrico
2Diamanti-Kandarakis, Evanthia
3Dokras, Anuja
4Escobar-Morreale, Hector F
5Futterweit, Walter
6Lobo, Rogerio
7Norman, Robert J
8Talbott, Evelyn
9Dumesic, Daniel A
formatjournal
genrearticle
ristypeJOUR
atitleAssessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
jtitleThe journal of clinical endocrinology and metabolism
addtitleJ Clin Endocrinol Metab
date2010-05
risdate2010
volume95
issue5
spage2038
epage2049
pages2038-2049
issn0021-972X
eissn1945-7197
codenJCEMAZ
abstractObjective: Women with polycystic ovary syndrome (PCOS) often have cardiovascular disease (CVD) risk factors. The Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society created a panel to provide evidence-based reviews of studies assessing PCOS-CVD risk relationships and to develop guidelines for preventing CVD. Participants: An expert panel in PCOS and CVD reviewed literature and presented recommendations. Evidence: Only studies comparing PCOS with control patients were included. All electronic databases were searched; reviews included individual studies/databases, systematic reviews, abstracts, and expert data. Articles were excluded if other hyperandrogenic disorders were not excluded, PCOS diagnosis was unclear, controls were not described, or methodology precluded evaluation. Inclusion/exclusion criteria were confirmed by at least two reviewers and arbitrated by a third. Consensus Process: Systematic reviews of CVD risk factors were compiled and submitted for approval to the AE-PCOS Society Board. Conclusions: Women with PCOS with obesity, cigarette smoking, dyslipidemia, hypertension, impaired glucose tolerance, and subclinical vascular disease are at risk, whereas those with metabolic syndrome and/or type 2 diabetes mellitus are at high risk for CVD. Body mass index, waist circumference, serum lipid/glucose, and blood pressure determinations are recommended for all women with PCOS, as is oral glucose tolerance testing in those with obesity, advanced age, personal history of gestational diabetes, or family history of type 2 diabetes mellitus. Mood disorder assessment is suggested in all PCOS patients. Lifestyle management is recommended for primary CVD prevention, targeting low-density and non-high-density lipoprotein cholesterol and adding insulin-sensitizing and other drugs if dyslipidemia or other risk factors persist. Guidelines for assessing cardiovascular risk and for primary prevention of cardiovascular diseases in PCOS.
copBethesda, MD
pubEndocrine Society
pmid20375205
doi10.1210/jc.2009-2724
oafree_for_read